Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03262259 · ClinicalTrials.gov registry record · NA

Evaluation of Global Smart Drinking Goals Initiative

A NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms, sponsored by HB.

Recruiting
Registry status
NA
Development phase
36,000
Enrollment target
1
Study location

NCT03262259 is a NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms that is actively recruiting participants, run by HB. The registered enrollment target is 36,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03262259, a NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms, is actively recruiting participants, sponsored by HB.

RECRUITING
Registry status
NA
Development phase
36,000 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate effects of a multi-component, population-level intervention on alcohol use and related harms in six intervention cities relative to six matched comparison cities. Intervention components include screening and brief interventions by health providers, other evidence-based interventions (e.g., enforcement of drink-driving or underage drinking laws), and novel or partially tested interventions that warrant further evaluation. Key outcomes of interest include alcohol-related harms such as alcohol-related motor vehicle crashes and fatalities, heavy/binge drinking, underage drinking, and drinking and driving.

Interventions

  • BEHAVIORAL GSDG multi-component intervention

Study Locations (1)

Maryland

  • HBSA - Calverton

Trial Details

FieldValue
Enrollment Target 36,000 participants
Start Date 2017-09-01
Est. Completion 2025-12-31
Phase NA

Sponsor

HB

1 total trials

What the Registry Record Tells You About NCT03262259

The ClinicalTrials.gov registry entry for NCT03262259 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HB, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms appearing as the primary indexed condition, and to 1 intervention - of which GSDG multi-component intervention is the first listed.

NCT03262259 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03262259 about?

NCT03262259 is a clinical study titled "Evaluation of Global Smart Drinking Goals Initiative". This study will evaluate effects of a multi-component, population-level intervention on alcohol use and related harms in six intervention cities relative to six matched comparison cities. Intervention components include screening and brief interventions by health providers, other evidence-based inte...

What is the current status of trial NCT03262259?

This trial is currently recruiting. It is a NA study. The enrollment target is 36,000 participants. The study started on 2017-09-01. Estimated completion is 2025-12-31.

What conditions does trial NCT03262259 study?

This clinical trial studies the following conditions: Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms.

What interventions are being tested in trial NCT03262259?

The interventions under investigation include: GSDG multi-component intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03262259?

This trial is sponsored by HB, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03262259 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.